A Novel Fc-Engineered Anti-HER2 Bispecific Antibody With Enhanced Antitumor Activity.
Mohammadi M, Jeddi-Tehrani M, Golsaz-Shirazi F, Arjmand M, Torkashvand F, Bahadori T, Judaki MA, Shiravi F, Ahmadi Zare H, Notash Haghighat F, Mobini M, Shokri F, Amiri MM.
Mohammadi M, et al.
J Immunother. 2023 May 1;46(4):121-131. doi: 10.1097/CJI.0000000000000464. Epub 2023 Mar 20.
J Immunother. 2023.
PMID: 36939675